Rankia España Rankia Argentina Rankia Brasil Rankia Chile Rankia Colombia Rankia Czechia Rankia Deutschland Rankia France Rankia Indonesia Rankia Italia Rankia Magyarország Rankia México Rankia Netherlands Rankia Perú Rankia Polska Rankia Portugal Rankia Romania Rankia Türkiye Rankia United Kingdom Rankia USA
Acceder

Farmas USA

135K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
14.042 / 16.979
#112330

Re: Farmas USA

RDUS

venga que las vuelvo a llevar rompe mas hdlgp!!!!

16,3 las llevo

SMA20 diaria a 16,88 y ha sido resistencia hasta la fecha … vamos a ver hoy … 

Hoy le hubiera metido a otras también, EXEL, TGTX …  Pero ya estoy 90% expuesto algo así … me da vértigo … y con 7 nombres ya vale leñe que luego me entra dolor de cabeza de tanto movimiento vertiginoso de pupila vigilándolo todo … 

 

#112331

Re: Farmas USA

RDUS

Como se me han escapado,, ains, las esperaba a 15.75

Pero ojo,, hoy es día de brujas y hasta los cierres, me parece que hoy solo a mirar.

#112333

Re: Farmas USA

Pues si que me duro poco la entrada de RDUS … soy como un perro amaestrado … veo esa vela y sin darme cuenta ya se me mueve el dedo solo … oye, que no me voy a quejar, 350 pavos

Y las REGN también las largué a 145. casi un +5%.

Y creo que voy a poner en even venta de las CELG, estoy hasta los webs de ellas, al menos no llevármelas el fin de semana.

edito: de hecho vuelvo a 100%, han sido buenos profits. solo me ha fallado la perra de FB. 

#112334

Re: Farmas USA

MLNT

Que cruz XD  -11% y no tengo más coj... que aguantarlas los meses que hagan falta.

#112335

Re: Farmas USA

RDUS

Framussss, en el grafico que has puesto no me cuadra a siple vista, la escala, ya que el día 2 llego a tocar los 19.41   Igual esa linea, no cuadra tanto... simple comentario,,

Edito: si al cierre no pierde los 16.13 igual entro,, pero con el finde por medio.. buff.

#112336

Re: Farmas USA

Synergy Collapse Due To Toxic CRG Loan Sends Shockwaves Throughout Biotech Sector

Nov. 16, 2018 10:30 AM ET        Jose Solorio

Long/short equity, special situations, healthcare, options

Summary

After one of the most promising stocks in the biotech sector has collapsed due to a toxic loan, a wave of hard selling has hit the biotech sector.

Synergy, who owns a drug capable of achieving blockbuster status, entered into a very toxic loan agreement capable of bringing it to the verge of bankruptcy.

CRG once heralded as one of the most flexible lenders for biotech companies, has shown its willingness to collapse a company for personal profit.

Biotech investors are selling stocks as questions arise of where possible funding can come from as interest rates rise and CRG makes moves that imply a Synergy takeover.

Industry trends and rising interest rates are making biotech stocks an easy target. Negative Equity returns are happening in the sector drying up capital available.

CRG imposed prepayment fees of up to 40% on their loan to Synergy which makes a possible refinancing transaction almost impossible to achieve

Another big casualty of the tighter funding standards has been Achaogen Pharmaceuticals (AKAO)

Even the top-tier sector stocks like Sangamo Therapeutics ( SGMO) have shown a significant decline in their stock price despite the fact they just achieved quarterly revenues of $23.5 million and have a cash balance of $460 million on their balance sheet and collaboration agreements with big pharmaceuticals with up to $5 billion in milestone payments.

Even Madrigal Pharmaceuticals ( MDGL) collapsed after reporting  positive datafor its Madrigal’s MGL-3196 in Non-Alcoholic Steatohepatitis (NASH) with readings so good potentially making it the best in its class

Invest carefully and remember that the trend is not looking very favorable in the short term for biotech investments. This trend is not going away soon and even positive catalysts on stocks are being sold off into strength.

https://seekingalpha.com/article/4222825-synergy-collapse-due-toxic-crg-loan-sends-shockwaves-throughout-biotech-sector

Guía Básica
Brokers destacados